Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.38583 | 54 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.22835 | 77 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.19546 | 77 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.16311 | 51 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.30488 | 54 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.32747 | 51 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.28935 | 50 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.24969 | 52 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.96487 | 66 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.43436 | 57 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.25042 | 52 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.24232 | 52 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.25581 | 51 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.26677 | 52 |